has semaglutide been banned Compounded GLP-1 ban: What providers need to know Weight loss wonder drugs Ozempic
Description
The MHRA has confirmed that retatrutide does not hold a UK marketing authorisation, and the risks of using unlicensed injectable compounds obtained outside approved trials are serious and cannot be fully mitigated by careful preparation alone
Selecting a Texas provider means verifying licensure, reviewing their experience with GLP-1 therapy, and confirming they use licensed 503A compounding pharmacies exclusively
PlexusDx compounded semaglutide injection delivers identical molecular structure to Ozempic, sourced from licensed 503A compounding pharmacies meeting FDA quality standards

Toutenburg H, Rubin DB

Many people find that as they lose weight on semaglutide, exercise becomes easier and more comfortable

In Canada, Ozempics eight-year data protection is scheduled to expire on January 4, 2026, opening the door for generic filings to receive market authorization
